Chester County News and Community Website
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) said it expects to complete enrollment in its pivotal BACKBEAT clinical trial by the end of the third quarter of …
Orchestra BioMed Targets 2027 Data for Hypertension Trial Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) received a $15 million investment from Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) tied to the company’s ongoing cardiovascular device trials, completing …
Orchestra BioMed Secures Ligand Funding for Pivotal Trials Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) received a $20 million investment from Medtronic plc (NYSE: MDT) tied to the companies’ ongoing collaboration to develop a pacemaker-based …
Orchestra BioMed Secures Medtronic Funding for Hypertension Trial Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) said the U.S. Food and Drug Administration granted a second Breakthrough Device Designation for its AVIM Therapy, expanding its potential …
Orchestra BioMed Gains Second FDA Breakthrough Designation Read More NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) reported its full-year 2025 financial results and said it is advancing two pivotal clinical trials for therapies targeting hypertension and …
Orchestra BioMed Reports 2025 Results, Advances Pivotal Clinical Trials Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that company management will participate in two upcoming institutional investor conferences in March, including live presentations and one-on-one meetings …
Orchestra BioMed to Present at Two Healthcare Conferences Read More NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) announced that its board compensation committee granted stock options to purchase an aggregate of 120,000 shares of common stock to …
Orchestra BioMed Grants Inducement Stock Options to Nine New Employees Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) granted stock options to purchase 151,250 shares of common stock to 12 recently hired employees, the company said following a …
Orchestra BioMed Grants New Hire Stock Options as Clinical Programs Advance Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) reported third-quarter financial results and detailed a series of strategic and regulatory milestones that collectively secured more than $147 million …
Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced it will host a business update call on Wednesday, November 12, at 8:00 a.m. ET to discuss a series …
Orchestra BioMed to Deliver Major Business Update Amid Rapid Clinical Momentum Read More